The current P/E ratio for Vericel stock as of Oct 9, 2024 is 4095.0. This is calculated based on the current EPS of $0.01 and the stock price of $40.95 per share.
The average historical PE ratio of Vericel for the last five years is 1774.02. The current price-to-earnings ratio of 4095.0 is 131% more than the historical average. In the past five years, VCEL's PE ratio reached its highest point in the Sep 2021 quarter at 4,880, when the stock price was $48.8 and the EPS was $0.01. The lowest point was recorded in the Jun 2021 quarter, when it reached 262.5 with a price of $52.5 and an EPS of $0.2.
Year | PE ratio | Change |
---|---|---|
2023 | N/A | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | 514.67 | N/A |
2019 | N/A | N/A |
2018 | N/A | N/A |
2017 | N/A | N/A |
2016 | N/A | N/A |
2015 | N/A | N/A |
2014 | N/A | N/A |
Currently, VCEL's PE ratio is above the 5 and 10-year averages.
When compared to its peer stock RPRX, VCEL's PE ratio is higher.
Stock name | PE ratio | Market cap |
---|---|---|
RPRX Royalty Pharma plc | 18.26 | $16.37B |
VCEL Vericel Corp | 4,095 | $2.01B |
NEOG Neogen Corp | N/A | $3.22B |
NURO NeuroMetrix Inc | N/A | $8.12M |
The price to earnings ratio for VCEL stock is 4,095 as of Oct 9, 2024.
The average PE ratio for VCEL stock over the past 5 years is 1774.02.
Over the last five years, the quarterly PE ratio reached a historic high of 4,880 in the Sep 2021 quarter.
The current price to earnings ratio of VCEL is 131% higher than the 5-year historical average.
VCEL's PE ratio of 4,095 is considered high because the company's stock price is trading at a higher multiple of earnings.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Oct 9, 2024), Vericel's stock price is $40.95. The earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $0.01. Therefore, Vericel's price to earnings ratio for today is 4,095. PE RATIO(4,095) = STOCK PRICE($40.95) / TTM EPS($0.01)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.